Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway
Crossref DOI link: https://doi.org/10.1007/s00432-017-2415-5
Published Online: 2017-04-11
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nan, Yang
Guo, Liyun
Song, Yunpeng
Wang, Le
Yu, Kai
Huang, Qiang
Zhong, Yue
Funding for this research was provided by:
the China National Natural Scientific Fund (81572490)
the Tianjin Science and Technology Committee (13JCZDJC31000)
License valid from 2017-04-11